KCM
FBT icon

Key Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Key Capital Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6
Closed -$1.21K – 752
2026
Q1 		$1.21K Buy
+6
New +$1.24K ﹤0.01% 589

Other funds holding FBT

BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Key Capital Management's FBT Position: Q2 2026 in Review

Key Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 6 shares — an estimated $1.21K sold.

Key Capital Management first reported a position in FBT in Q1 2026 and held it in 1 quarter. The position peaked at $1.21K in Q1 2026. 191 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Key Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Key Capital Management sold 6 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.21K.
  • Key Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and held it in 1 quarter.
  • Key Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.21K in Q1 2026.
  • 191 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.